Ultragenyx Pharmaceutical Inc. — Investor Relations & Filings

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that develops and commercializes novel therapies for rare and ultra-rare genetic diseases. The company focuses on providing treatments for serious conditions that often have no approved therapies. Its core activities include the identification, acquisition, and development of a diverse portfolio of product candidates. Ultragenyx maintains a robust clinical pipeline that utilizes various therapeutic modalities, including biologics, small molecules, and gene therapy. The company has established one of the industry's largest advanced clinical gene therapy portfolios, aiming to deliver transformative treatments to patients with limited or no therapeutic options.